Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Treponema pallidum | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1351 | 0.5 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1351 | 0.5 | 0.5 |
Plasmodium falciparum | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1351 | 0.5 | 0.5 |
Mycobacterium leprae | PROBABLE 1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE DXR (DXP REDUCTOISOMERASE) (1-DEOXYXYLULOSE-5-PHOSPHATE REDUCTOISOMERAS | 0.1351 | 0.5 | 0.5 |
Mycobacterium ulcerans | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1351 | 0.5 | 0.5 |
Toxoplasma gondii | 1-deoxy-D-xylulose 5-phosphate reductoisomerase, putative | 0.1351 | 0.5 | 0.5 |
Plasmodium vivax | 1-deoxy-D-xylulose 5-phosphate reductoisomerase, putative | 0.1351 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | 0 | Inhibition of the replication of human immunodeficiency virus (HIV) at 10 microM concentration; NE=No effect | ChEMBL. | No reference |
Activity (functional) | 0 | Effect on replication of herpes simplex virus type 1 at a concentration of 300 microM; NE=No effect | ChEMBL. | No reference |
Activity (functional) | 0 | Effect on replication of herpes simplex virus type 2 at a concentration of 300 microM; NE=No effect | ChEMBL. | No reference |
Activity (functional) | 0 | Effect on replication of varicella zoster virus at a concentration of 300 microM; NE=No effect | ChEMBL. | No reference |
Activity (functional) | 0 | Effect on replication of cytomegalovirus at a concentration of 300 microM; NE=No effect | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.